Translocation (3;5)(p26;q13) in a patient with chronic T-cell lymphoproliferative disorder

Cancer Genetics and Cytogenetics

Volumn 104, Issue 2, 1998, Pages 82-85

  Schmidt, Helmut H ^a   Pirc Danoewinata, Hendrati ^b   Panzer Grümayer, Eva R ^b   Sill, Heinz ^a   Sedlmayr, Peter ^a   Neumeister, Peter ^a   Linkesch, Werner ^a   Haas, Oskar A ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD16 ANTIGEN; CD19 ANTIGEN; CD22 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; RAF PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

AGED; ARTICLE; CASE REPORT; CHROMOSOME 3P; CHROMOSOME TRANSLOCATION 3; CHRONIC LEUKEMIA; FLUORESCENCE ACTIVATED CELL SORTER; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE GRANULAR LYMPHOCYTE; LEUKEMOGENESIS; LYMPHOPROLIFERATIVE DISEASE; MALE; ONCOGENE; PRIORITY JOURNAL; T CELL LEUKEMIA; VON HIPPEL LINDAU DISEASE;

AGED; ANTIGENS, CD; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 5; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC; MALE; TRANSLOCATION, GENETIC;

EID: 0032527578     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00453-6     Document Type: Article

References (25)

1. Loughran T.P. Clonal diseases of large granular lymphocytes. Blood. 82:1993;1-14.
2. Bennett J.M., Juliusson G., Mecucci C. Morphologic, immunologic and cytogenetic classification of the chronic (mature) B and T lymphoid leukemias. fourth meeting of the MIC cooperative study group Canc Res. 50:1990;2212.
3. Loughran T.P., Starkebaum G., Aprile J.A. Rearrangement and expression of T-cell receptor genes in large granular lymphocyte leukemia. Blood. 71:1988;822-824.
4. Oshimi K. Granular lymphocyte proliferative disorders. report of 12 cases and review of the literature Leukemia. 2:1988;617-627.
5. Horstmann M., Argyriou-Tirita A., Borkhardt A., Kabisch H., Kapaun P., Winkler H., Haas O.A. MLL/ENL fusion in congenital acute lymphoblastic leukemia with a unique t(11;18;19). Cancer Genet Cytogenet. 88:1996;103-109.
6. Panzer-Grümayer E.R., Panzer S., Wolf M., Majdic O., Haas O.A., Kersey J.H. Characterization of CD7+ CD19+ lymphoid cells after Epstein-Barr virus transformation. J Immunol. 151:1993;92-99.
7. Medeiros L.J., Bagg A., Cossman J. Molecular genetics in the diagnosis and classification of lymphoid neoplasms. Jaffe E.S. Surgical Pathology of the Lymph Nodes and Related Organs. 2:1995;58-97 W. B. Saunders, Philadelphia.
8. Brito-Babapulle V., Matutes E., Foroni L., Pomfret M., Catovsky D. A t(8;14)(q24;q32) in a T-lymphoma/leukemia of CD8+ large granular lymphocytes. Leukemia. 1:1987;789-794.
9. Loughran T.P., Kadin M.E., Starkebaum G., Abkowitz J.L., Clark E.A., Disteche C., Lum L.G., Slichter S.J. Leukemia of large granular lymphocytes. association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia and hemolytic anemia Ann Int Med. 102:1985;169-175.
10. McKenna R.W., Arthur D.C., Gajl-Peczalska K.J., Flynn P., Brunning R.D. Granulated T cell lymphocytosis with neutropenia. malignant or benign chronic lymphoproliferative disorder? Blood. 66:1985;259-266.
11. Brody J.I., Burningham R.A., Nowell P.C., Rowlands D.T., Freiburg P., Daniele R.P. Persistent lymphocytosis with chromosomal evidence of malignancy. Am J Med. 58:1975;547-552.
12. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia, 2nd Ed., Elsevier Science Publishing Co., New York.
13. Juliusson G., Gharton G. Cytogenetics in CLL and related disorders. Baillieres Clin Haematol. 6:1993;821-848.
14. Mittelman F (1994): Catalog of Chromosome Aberrations in Cancer, 5th Ed., Wiley-Liss, New York.
15. Miyamoto K., Tomita N., Ishii A., Miyamoto N., Nonaka H., Kondo T., Sugihara T., Yawata Y., Tada S., Tsubota T. Specific abnormalities of chromosome 14 in patients with acute type of adult T-cell leukemia/lymphoma. Int J Cancer. 40:1987;461-468.
16. Miyamoto K., Tomita N., Ishii A., Miyamoto N., Nonaka H., Kondo T., Tanaka T., Kitajima K. Chromosome abnormalities of leukemia cells in adult patients with T-cell leukemia. J Natl Cancer Inst. 73:1984;353-362.
17. Fairman J., Wang R.Y., Liang H., Zhao L., Saltman D., Liang J.C., Nagarajan L. Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia. evidence for a novel critical locus Blood. 88:1996;2259-2266.
18. Haglund U., Juliusson G., Stellan B., Gahrton G. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood. 83:1994;2637-2645.
19. Werner M., Nolte M., Kaloutsi V., Buhr T., Kausche F., Georgii A. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders. Lab Invest. 72:1995;405-410.
20. Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L., Stackhouse T., Kuzmin I., Modi W., Geil L. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1993;1317-1320.
21. Shuin T., Kondo K., Torigoe S., Kishida T., Kubota Y., Hosaka M., Nagashima Y., Kitamura H., Latif F., Zbar B., Lerman M.I., Yao M. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinoma. Cancer Res. 54:1994;2852-2855.
22. Li P., Wood K., Mamon H., Haser W., Roberts T. Raf-1. a kinase currently without a cause but not lacking in effects Cell. 64:1991;479-482.
23. Okuda K., Matulonis U., Salgia R., Kanakura Y., Druker B., Griffin J.D. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1. Exp Hematol. 22:1994;1111-1117.
24. Magnuson N.S., Beck T., Vahidi H., Hahn H., Smola U., Rapp U.R. The Raf-1 serine/threonine protein kinase. Semin Cancer Biol. 5:1994;247-253.
25. Owaki H., Varma R., Gillis B., Bruder J.T., Rapp U.R., Davis L.S., Geppert T.D. Raf-1 is required for T cell IL-2 production. EMBO. 12:1993;4367-4373.